» Articles » PMID: 19228399

High Resolution Preparation of Monocyte-derived Macrophages (MDM) Protein Fractions for Clinical Proteomics

Overview
Journal Proteome Sci
Publisher Biomed Central
Date 2009 Feb 21
PMID 19228399
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Macrophages are involved in a number of key physiological processes and complex responses such as inflammatory, immunological, infectious diseases and iron homeostasis. These cells are specialised for iron storage and recycling from senescent erythrocytes so they play a central role in the fine tuning of iron balancing and distribution. The comprehension of the many physiological responses of macrophages implies the study of the related molecular events. To this regard, proteomic analysis, is one of the most powerful tools for the elucidation of the molecular mechanisms, in terms of changes in protein expression levels.

Results: Our aim was to optimize a protocol for protein fractionation and high resolution mapping using human macrophages for clinical studies. We exploited a fractionation protocol based on the neutral detergent Triton X-114. The 2D maps of the fractions obtained showed high resolution and a good level of purity. Western immunoblotting and mass spectrometry (MS/MS analysis) indicated no fraction cross contamination. On 2D-PAGE mini gels (7 x 8 cm) we could count more than five hundred protein spots, substantially increasing the resolution and the number of detectable proteins for the macrophage proteome. The fractions were also evaluated, with preliminary experiments, using Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry (SELDI-TOF-MS).

Conclusion: This relatively simple method allows deep investigation into macrophages proteomics producing discrete and accurate protein fractions, especially membrane-associated and integral proteins. The adapted protocol seems highly suitable for further studies of clinical proteomics, especially for the elucidation of the molecular mechanisms controlling iron homeostasis in normal and disease conditions.

Citing Articles

In-Depth Proteomic Characterization of Classical and Non-Classical Monocyte Subsets.

Segura V, Luz Valero M, Cantero L, Munoz J, Zarzuela E, Garcia F Proteomes. 2018; 6(1).

PMID: 29401756 PMC: 5874767. DOI: 10.3390/proteomes6010008.


Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study.

Duhamel M, Rodet F, Delhem N, Vanden Abeele F, Kobeissy F, Nataf S Mol Cell Proteomics. 2015; 14(11):2857-77.

PMID: 26330543 PMC: 4638031. DOI: 10.1074/mcp.M115.052480.


Quantitative proteomic analysis of host--pathogen interactions: a study of Acinetobacter baumannii responses to host airways.

Antonio Mendez J, Mateos J, Beceiro A, Lopez M, Tomas M, Poza M BMC Genomics. 2015; 16:422.

PMID: 26025090 PMC: 4449591. DOI: 10.1186/s12864-015-1608-z.


Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.

Refaie S, Gagnon S, Gagnon H, Desjardins R, DAnjou F, DOrleans-Juste P J Biol Chem. 2012; 287(18):14703-17.

PMID: 22396549 PMC: 3340273. DOI: 10.1074/jbc.M111.323220.

References
1.
Swinkels D, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna E . Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One. 2008; 3(7):e2706. PMC: 2442656. DOI: 10.1371/journal.pone.0002706. View

2.
Bozzini C, Campostrini N, Trombini P, Nemeth E, Castagna A, Tenuti I . Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis. 2008; 40(3):347-52. DOI: 10.1016/j.bcmd.2007.10.001. View

3.
Ofarrell P . High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975; 250(10):4007-21. PMC: 2874754. View

4.
Righetti P, Castagna A, Herbert B, Reymond F, Rossier J . Prefractionation techniques in proteome analysis. Proteomics. 2003; 3(8):1397-407. DOI: 10.1002/pmic.200300472. View

5.
De Domenico I, Ward D, Kaplan J . Hepcidin regulation: ironing out the details. J Clin Invest. 2007; 117(7):1755-8. PMC: 1904333. DOI: 10.1172/JCI32701. View